Scarica l'app Stockscreener
9.42
0.11%
0.010
Dopo l'orario di chiusura:
9.55
0.13
+1.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALVR Giù?
Forum
Previsione
Precedente Chiudi:
$9.41
Aprire:
$9.74
Volume 24 ore:
14,310
Relative Volume:
0.57
Capitalizzazione di mercato:
$47.48M
Reddito:
-
Utile/perdita netta:
$-168.86M
Rapporto P/E:
-5.6071
EPS:
-1.68
Flusso di cassa netto:
$-125.29M
1 W Prestazione:
-6.82%
1M Prestazione:
-2.48%
6M Prestazione:
-44.73%
1 anno Prestazione:
-43.12%
Intervallo 1D:
$9.42
$9.74
Intervallo di 1 settimana:
$9.37
$10.40
Portata 52W:
$7.96
$24.15
Allovir Inc Stock (ALVR) Company Profile
Nome
Allovir Inc
Settore
Industria
Telefono
(617) 433-2605
Indirizzo
1100 WINTER STREET, WALTHAM
Confronta ALVR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALVR
Allovir Inc
|
9.42 | 47.48M | 0 | -168.86M | -125.29M | -1.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Allovir Inc Stock (ALVR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-26 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| 2023-12-22 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-08-18 | Iniziato | BofA Securities | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2020-08-24 | Iniziato | JP Morgan | Overweight |
| 2020-08-24 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-24 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Allovir Inc Borsa (ALVR) Ultime notizie
Allovir director Vikas Sinha sells $1,225 in stock - MSN
Allovir's chief accounting officer sells $342 in common stock - MSN
Allovir's general counsel sells $494 in stock - MSN
Allovir's general counsel sells $494 in stock By Investing.com - Investing.com South Africa
Allovir's chief accounting officer sells $342 in common stock By Investing.com - Investing.com South Africa
Allovir director Vikas Sinha sells $1,225 in stock By Investing.com - Investing.com Australia
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline - GuruFocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCYTH, ALVR, WMPN, OMC - Morningstar
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Inve - GuruFocus.com
AlloVir (NASDAQ:ALVR) Trading 8.2% HigherHere's What Happened - MarketBeat
The Law Offices of Vincent Wong Remind AlloVir Investors of a Lead Plaintiff Deadline of March 19, 2024 - Marketscreener.com
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - Marketscreener.com
AlloVir (NASDAQ:ALVR) Hits New 1-Year LowWhat's Next? - MarketBeat
SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options - Marketscreener.com
ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc.ALVR - Marketscreener.com
Shareholder Alert: Ademi LLP Investigates Whether AlloVir, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Marketscreener.com
AlloVir, Inc. Enter into Termination of Sublease Agreement with AMAG Pharmaceuticals, Inc - Marketscreener.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir - Marketscreener.com
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. LawsuitALVR - Marketscreener.com
Jane Street Group LLC Sells 89,680 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World
AlloVir executes reverse stock split By Investing.com - Investing.com Australia
AlloVir executes reverse stock split - Investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Allovir stock plunges to 52-week low, touches $0.4 By Investing.com - Investing.com Australia
Allovir’s Vikas Sinha sells shares worth $430 By Investing.com - Investing.com Nigeria
Allovir's Vikas Sinha sells shares worth $430 By Investing.com - Investing.com Australia
Allovir’s general counsel Edward Miller sells $180 in stock By Investing.com - Investing.com Nigeria
Allovir’s chief accounting officer sells $146 in common stock By Investing.com - Investing.com Nigeria
Allovir's chief accounting officer sells $146 in common stock By Investing.com - Investing.com Australia
Allovir's general counsel Edward Miller sells $180 in stock By Investing.com - Investing.com Australia
Allovir's chief accounting officer sells $146 in common stock - Investing.com India
Allovir's general counsel Edward Miller sells $180 in stock - Investing.com India
Allovir stock plunges to 52-week low, touches $0.4 - Investing.com India
Geode Capital Management LLC Lowers Stock Position in AlloVir, Inc. (NASDAQ:ALVR) - Defense World
Reviewing AlloVir (NASDAQ:ALVR) and Turnstone Biologics (NASDAQ:TSBX) - Defense World
AlloVir, Inc. Reports Positive Voting Outcome for Proposed Reverse Stock Split - Defense World
AlloVir announces reverse stock split effective January 16 By Investing.com - Investing.com Australia
AlloVir announces reverse stock split effective January 16 - Investing.com India
AlloVir shareholders approve reverse stock split - Investing.com
Allovir Inc Azioni (ALVR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):